We are very pleased to announce that SpinalCure Australia has been chosen as this year’s Australian Turf Club Charity Partner of the Year. Founded from the merger of the Australian Jockey’s Club and Sydney Turf Club…
Queensland researchers are launching a world-first clinical trial aimed at improving recovery from spinal cord injuries.
In the study, led by The University of Queensland and The Princess Alexandra (PA) Hospital, a new anti-inflammatory drug will be given to participants within hours of spinal trauma in an effort to minimise tissue damage. Dr Marc Ruitenberg from the UQ…
FOR IMMEDIATE RELEASE
SpinalCure Australia, the not-for-profit dedicated to facilitating and funding research to end the permanence of spinal cord injury, is delighted to announce a major five-year donation of $3 million from the Neilson Foundation.
Research aiming to reverse the paralyzing effects of spinal cord injuries (SCI) that devastate the lives of so many Australians and their families will soon begin at the University of Technology Sydney (UTS).
We are delighted to announce that on 2nd December 2015, Lloyd’s Australia along with major sponsors SLE Worldwide, XL Catlin and Brooklyn Underwriting, will host its inaugural Charity Golf Day in support of SpinalCure.
Rapid treatment with a new anti-inflammatory could have a major impact on recovery from spinal cord injury, University of Queensland researchers have found.
The prospect of future breakthroughs in spinal cord injury treatment has been boosted with the joint announcement today of a new medical research Fellowship, according to the Royal Australasian College of Physicians.
Queensland scientists have advanced a potential new treatment for spinal cord injury with a view to starting clinical trials.